Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
AstraZeneca
Ann R Falsey; Magdalena E Sobieszczyk; Ian Hirsch; Stephanie Sproule; Merlin L Robb; Lawrence Corey; Kathleen M Neuzil; William Hahn; Julie Hunt; Mark J Mulligan; Charlene McEvoy; Edwin DeJesus; Michael Hassman; Susan J Little; Barbara A Pahud; Anna Durbin; Paul Pickrell; Eric S Daar; Larry Bush; Joel Solis; Quito Osuna Carr; Temitope Oyedele; Susan Buchbinder; Jessica Cowden; Sergio L Vargas; Alfredo Guerreros Benavides; Robert Call; Michael C Keefer; Beth D Kirkpatrick; John Pullman; Tina Tong; Margaret Brewinski Isaacs; David Benkeser; Holly E Janes; Martha C Nason; Justin A Green; Elizabeth J Kelly; Jill Maaske; Nancy Mueller; Kathryn Shoemaker; Therese Takas; Richard P Marshall; Menelas N Pangalos; Tonya Villafana; Antonio Gonzalez-Lopez; AstraZeneca AZD1222 Clinical Study Group